Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

Witkiewicz, Agnieszka K., McMillan, Elizabeth A., Balaji, Uthra, Baek, GuemHee, Lin, Wan-Chi, Mansour, John, Mollaee, Mehri, Wagner, Kay-Uwe +7 more·2015·Nature Communications

DOI 10.1038/ncomms7744

Cited by (1,000)

Items 601–700 of 1,000

DNA sequencing of cytopathologically inconclusive EUS-FNA from solid pancreatic lesions suspicious for malignancy confirms EUS diagnosis
Julie Isabelle Plougmann Gislinge, Pia Helene Klausen, Anders Toxværd, Armita Armina Abedi, Bojan Kovacevic, JohnGásdal Karstensen, Tim Svenstrup Poulsen, Evangelos Kalaitzakis, Estrid Vilma Solyom Høgdall, Peter Vilmann · 2019 · Endoscopic Ultrasound
Comprehensive Analysis of Molecular Biologic Characteristics of Pancreatic Ductal Adenocarcinoma Concomitant with Intraductal Papillary Mucinous Neoplasm
Masahiro Tsujimae, Atsuhiro Masuda, Takuya Ikegawa, Takeshi Tanaka, Jun Inoue, Hirochika Toyama, Keitaro Sofue, Hisahiro Uemura, Shinya Kohashi, Noriko Inomata et al. · 2022 · Annals of Surgical Oncology
FGFR2 fusion in metastatic pancreatic ductal adenocarcinoma: Is there hope?
Clara Helal, Marine Valéry, Michel Pierre Ducreux, Antoine Hollebecque, Cristina Smolenschi · 2022 · European Journal of Cancer
Efficacy of dabrafenib/trametinib in pancreatic ductal adenocarcinoma with BRAF NVTAP deletion: A case report
Ji Eun Shin, Ho Jung An, Hyung Soon Park, Hyunho Kim, Byoung Yong Shim · 2022 · Frontiers in Oncology
ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration
Jennifer R. Kosinski, Antonio S. Sechi, Johanna Hain, Sophia Villwock, Stefanie Anh Ha, Maximilian Hauschulz, Michael Rose, Florian Steib, Nadina Ortiz‐Brüchle, Lara Rosaline Heij et al. · 2024 · Molecular Oncology
ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and identifies actionable alterations in fast progressing patients
Marisol Huerta, Jorge Martín-Arana, Francisco Gimeno-Valiente, Juan Antonio Carbonell‐Asins, Blanca García-Micó, Belén Martínez-Castedo, Fabián Robledo-Yagüe, Daniel G. Camblor, Tania Fleitas, Miguel García Bartolomé et al. · 2024 · Translational research
Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic Samples
Warapen Treekitkarnmongkol, Jianliang Dai, Suyu Liu, Deivendran Sankaran, Tristian Nguyen, Seetharaman Balasenthil, Mark W. Hurd, Meng Chen, Hiroshi Katayama, Sinchita Roy‐Chowdhuri et al. · 2024 · Gastro Hep Advances
Potency and Safety of KRAS G12C Inhibitors in Solid Tumors: A Systematic Review
Sara El Zaitouni, Abdelilah Laraqui, Youssra Boustany, Soukaina Benmokhtar, Hicham El Annaz, Rachid Abi, Mohamed Rida Tagajdid, Safae El Kochri, El Arbi Bouaiti, Idriss Lahlou Amine et al. · 2025 · Clinical Medicine Insights Oncology
Polybromo 1/vimentin axis dictates tumor grade, epithelial-mesenchymal transition, and metastasis in pancreatic cancer
Munenori Kawai, A. Fukuda, Munehiro Ikeda, Kei Iimori, Kenta Mizukoshi, Kosuke Iwane, Go Yamakawa, Mayuki Omatsu, Mio Namikawa, M. Sono et al. · 2025 · Journal of Clinical Investigation
Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients
Mi‐Ju Kim, Min‐Sun Kim, Sung Joo Kim, Soyeon An, Hosub Park, Hosub Park, Jae Hoon Lee, Ki-Byung Song, Dae Wook Hwang, Suhwan Chang et al. · 2017 · Cancer Cell International
SETD2 as a regulator of N6-methyladenosine RNA methylation and modifiers in cancer
Subhadra Kumari, Srinivasan Muthusamy · 2020 · European Journal of Cancer Prevention
Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017
Ding Ding, Ammar A. Javed, Dea Cunningham, Jonathan A. Teinor, Michael J. Wright, Zunaira N. Javed, Cara Wilt, Lindsay Parish, Mary B. Hodgin, A. Ryan et al. · 2020 · Cancer Letters
Molecular Peritoneal Staging for Pancreatic Ductal Adenocarcinoma Using Mutant KRAS Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical Trial
Jennifer A. Yonkus, Roberto Alva‐Ruiz, Amro M. Abdelrahman, Jennifer L. Leiting, Amber R. Schneider, Travis Edward Grotz, Sean Patrick Cleary, Rory L. Smoot, David M. Nagorney, Michael L. Kendrick et al. · 2021 · Journal of the American College of Surgeons
Relationship between cellular morphology and abnormality of SWI/SNF complex subunits in pancreatic undifferentiated carcinoma
Takeo Yamamoto, Kenichi Kohashi, Yutaka Yamada, Jun Kawata, Kukiko Sakihama, Ryota Matsuda, Yutaka Koga, Shinichi Aishima, Masafumi Nakamura, Yoshinao Oda · 2021 · Journal of Cancer Research and Clinical Oncology
Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts
Dietrich Alexander Ruess, Kıvanç Görgülü, Sonja M. Wörmann, Hana Algül · 2017 · Drugs & Aging
Synthetic lethal targeting of RNF20 through PARP1 silencing and inhibition
Brent J. Guppy, Kirk James McManus · 2017 · Cellular Oncology
Genetics of pancreatic cyst-cancer progression: standing on the shoulders of giants
Bhuwan Giri, Vrishketan Sethi, Vikas Dudeja, Sulagna Banerjee, Alan S. Livingstone, Ashok Kumar Saluja · 2017 · Current Opinion in Gastroenterology
Pre-neoplastic pancreas cells enter a partially mesenchymal state following transient TGF-β exposure
Jesse Stone Handler, Jane E. Cullis, Antonina Avanzi, Emily Vucic, Dafna Bar‐Sagi · 2018 · Oncogene
GNAS shifts metabolism in pancreatic cancer
Pablo E. Hollstein, Reuben J. Shaw · 2018 · Nature Cell Biology
An Organotypic Microcosm for the Pancreatic Tumor Microenvironment
Miranda Lin, Mei Gao, Prakash Krishnan Pandalai, Michael J. Cavnar, Joseph Kim · 2020 · Cancers
RETRACTED ARTICLE: Nanoformulation of Apolipoprotein E3-Tagged Liposomal Nanoparticles for the co-Delivery of KRAS-siRNA and Gemcitabine for Pancreatic Cancer Treatment
Fengyong Wang, Zhen Zhang · 2020 · Pharmaceutical Research · Retracted
VDAP-GUI: a user-friendly pipeline for variant discovery and annotation of raw next-generation sequencing data
Ramesh Menon, Namrata V. Patel, Amitbikram Mohapatra, Chaitanya G. Joshi · 2016 · 3 Biotech
A gene mutation in RNA‑binding protein 10 is associated with lung adenocarcinoma progression and poor prognosis
Linlin Yin, Xin‐Mian Wen, Ming Li, Yanmei Xu, Xiaofeng Zhao, Jing Li, Xiuwen Wang · 2018 · Oncology Letters
CoDEX2: full-spectrum copy number variation detection by high-throughput DNA sequencing
Yuchao Jiang, Rujin Wang, Eugene Urrutia, Ioannis N. Anastopoulos, Katherine L. Nathanson, Nancy Ruonan Zhang · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal adenocarcinoma patients: a case report
Bach Ardalan, Jose Ignacio Azqueta, Jonathan S. England, Tiffany Alyssa Eatz · 2021 · Molecular Case Studies
A TP53-associated immune prognostic signature for the prediction of the overall survival and therapeutic responses in pancreatic cancer
Liu, Yi, Department of Colorectal and Anal Surgery, The First Hospital of Jilin University, Changchun, Jilin, China, Cheng, Long, Song, Xiangyang, Li, Chao, Zhang, Jiantao, Wang, Lei, Department of Orthopedics, The First Hospital of Jilin University, Changchun, Jilin, China, Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Street Xinmin 71, Changchun, China · 2022 · Mathematical Biosciences and Engineering
Genetic alterations and functional networks of m6A RNA methylation regulators in pancreatic cancer based on data mining
Juan Zeng, Heying Zhang, Yonggang Tan, Zhe Wang, Yunwei Li, Xianghong Yang · 2021 · Journal of Translational Medicine
Pathology and Molecular Characteristics of Pancreatic Cancer
Joseph F. Kearney, Volkan N. Adsay, Jen Jen Yeh · 2021 · Surgical Oncology Clinics of North America
Challenges in genomic analysis of model systems and primary tumors of pancreatic ductal adenocarcinoma
Sangyeop Hyun, Daechan Park · 2022 · Computational and Structural Biotechnology Journal
The KRAS signaling pathway's impact on the characteristics of pancreatic cancer cells
Meiyan Chen, Meiyan Chen, Yuka Fu, Jingyi Zhang · 2023 · Pathology - Research and Practice
Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
Emilia Alors‐Pérez, Sergio Pedraza‐Arévalo, Ricardo Blázquez‐Encinas, María Trinidad Moreno-Montilla, Víctor García‐Vioque, Inmaculada Berbel, Raul Miguel Luque, Bruno Sáinz, Alejandro Ibáñez‐Costa, Justo Pastor Castano · 2023 · Journal of Experimental & Clinical Cancer Research
Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease
Fergus Keane, Joanne F. Chou, Henry S. Walch, Joshua David Schoenfeld, Anupriya Singhal, Darren Cowzer, Emily C. Harrold, Catherine Anne O'Connor, Wungki Park, Anna M. Varghese et al. · 2024 · JNCI Journal of the National Cancer Institute
Splicing dysregulation: hallmark and therapeutic opportunity in pancreatic cancer
Chiara Naro, Veronica Ruta, Claudio Sette · 2024 · Trends in Molecular Medicine
A safe haven for cancer cells: tumor plus stroma control by DYRK1B
Miriam Ems, Anna I. Brichkina, Matthias Lauth · 2025 · Oncogene
Genetics of pancreatic cancer and implications for therapy
Priya Bhosale, Veronica L. Cox, Silvana Castro Faria, Sanaz Javadi, Chitra Viswanathan, Eugene Jon Koay, Eric Peter Tamm · 2017 · Abdominal Radiology
A cellular and bioinformatics analysis of the SENP1 SUMO isopeptidase in pancreatic cancer
Danielle Bouchard, Michael J. Matunis · 2019 · Journal of Gastrointestinal Oncology
Spred-3 mutation and Ras/Raf/MAPK activation confer acquired resistance to EGFR tyrosine kinase inhibitor in an EGFR mutated NSCLC cell line
Zhiyong He, Fusheng Gong, Jinrong Liao, Qiang Wang, Ying Su, Chao Chen, Jinghui Lin, Ren-Jang Lin · 2020 · Translational Cancer Research
Genomic investigation of co-targeting tumor immune microenvironment and immune checkpoints in pan-cancer immunotherapy
Xing Huang, Tianyu Tang, Gang Zhang, Zhengtao Hong, Jian Xu, Dipesh Kumar Yadav, Xueli Bai, Tingbo Liang · 2020 · npj Precision Oncology
Targeted Transcriptome and KRAS Mutation Analysis Improve the Diagnostic Performance of EUS-FNA Biopsies in Pancreatic Cancer
Joanne Lundy, Hugh Gao, William Berry, Samar Masoumi Moghaddam, Brendan John Jenkins, Daniel Gerald Croagh · 2021 · Clinical Cancer Research
The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells
Chitra Palanivel, Neha Chaudhary, Parthasarathy Seshacharyulu, Jesse L. Cox, Ying Yan, Surinder K. Batra, Michel M. Ouellette · 2022 · Neoplasia
Glypican 1 promotes proliferation and migration in esophagogastric adenocarcinoma via activating AKT/GSK/β-catenin pathway
Akshay Pratap, Anqi Li, Lindsey M. Westbrook, Anna K. Gergen, Sanchayita Mitra, Argudit Chauhan, Linling Cheng, Michael J. Weyant, Martin D. McCarter, Sachin B. Wani et al. · 2022 · Journal of Gastrointestinal Oncology
Liquid biopsy leads to a paradigm shift in the treatment of pancreatic cancer
Fumiaki Watanabe, Koichi Suzuki, Hiroshi Noda, Toshiki Rikiyama · 2022 · World Journal of Gastroenterology
Advanced pancreatic cancer with KRAS wild-type and EGFR-sensitive mutation respond favorably to furmonertinib: A case report
Xiaoting Ma, Xiu Liu, Kai Ou, Manman Zhang, Lizhen Gao, Lin Yang · 2023 · Frontiers in Oncology
Expression of RNA-binding motif 10 is associated with advanced tumor stage and malignant behaviors of lung adenocarcinoma cancer cells
Guofang Guan, Ranwei Li, Wen‐Fang Tang, Tiecheng Liu, Zhenzhong Su, Yan Wang, Tan Jingjin, Shan Jiang, Ke Wang · 2017 · Tumor Biology
Duktales Adenokarzinom des Pankreas
Eike Gallmeier, Thomas Mathias Gress · 2018 · Der Internist
Hypoxia-Dependent Expression of TG2 Isoforms in Neuroblastoma Cells as Consequence of Different MYCN Amplification Status
Monica Currò, Nadia Ferlazzo, Maria Laura Giunta, Angela Simona Montalto, Tiziana Russo, Salvatore Arena, Pietro Impellizzeri, Daniela Caccamo, Carmelo Romeo, Riccardo Ientile · 2020 · International Journal of Molecular Sciences
The GNAQ T96S Mutation Affects Cell Signaling and Enhances the Oncogenic Properties of Hepatocellular Carcinoma
Eugene Jinkyu Choi, Sung Jean Park, Gunhee Lee, Seung Kew Yoon, Minho Lee, Suk Kyeong Lee · 2021 · International Journal of Molecular Sciences
Unraveling Tumor Heterogeneity by Using DNA Barcoding Technologies to Develop Personalized Treatment Strategies in Advanced-Stage PDAC
Philip Dujardin, Anna K. Baginska, Sebastian Urban, Barbara M. Grüner · 2021 · Cancers
Molecular, metabolic, and histological subtypes of pancreatic ductal adenocarcinoma and its tumor microenvironment: Insights into tumor heterogeneity and clinical implications
Yuuki Ohara, Huaitian Liu, Paloma Moreno, Seiya Suzuki, S. Perwez Hussain · 2025 · Pharmacology & Therapeutics
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer
Sandrine Barbier, Benjamin Beaufils, Ricardo de Miguel, Melissa Reyre, Yannick Le Meitour, Andréanne Lortie, Marc Hillairet de Boisferon, Sophie Chaumeron, Anne Espirito, Lina Fossati et al. · 2023 · Oncology and Therapy
Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such as serpin E1 and CCL5
Jiali Gong, Xiawei Li, Zengyu Feng, Jianyao Lou, Kaiyue Pu, Yongji Sun, Sien Hu, Yizhao Zhou, Tianyu Song, Meihua Shangguan et al. · 2024 · Experimental & Molecular Medicine
A genome‐scale screen reveals context‐dependent ovarian cancer sensitivity to miRNA overexpression
Benjamin B. Shields, Chad Victor Pecot, Hua Gao, Elizabeth A. McMillan, Malia B. Potts, Christa Irene Nagel, Scott C. Purinton, Ying Wang, Cristina Ivan, Hyun Seok Kim et al. · 2015 · Molecular Systems Biology
New insights in the development of pancreatic cancer
Smrita Sinha, Steven D. Leach · 2016 · Current Opinion in Gastroenterology
Personalized Management of Pancreatic Ductal Adenocarcinoma Patients through Computational Modeling
Kimiyo N. Yamamoto, Shinichi Yachida, Akira Nakamura, Atsushi Niida, Minoru Oshima, Subhajyoti De, Lauren M. Rosati, Joseph M. Herman, Christine A. Iacobuzio–Donahue, Hiroshi Haeno · 2017 · Cancer Research
Distinct Patterns of Somatic Genomic Alterations and Mutational Signatures in Central and Peripheral-Type Small-Cell Lung Cancer
Lei Wang, Jing Wang, Juanni Hu, Lele Song, Jian Ni, Yayi He, Caicun Zhou · 2020 · Translational Lung Cancer Research
Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR)
Raúl Muñoz Velasco, Paula Jiménez Sánchez, Ana García García, Raquel Blanco Martínez-Illescas, Ángela Pastor Senovilla, Marian Lozano Yagüe, Alfonsina Trento, Rosa García-Martín, Diego Navarro, Bruno Sáinz et al. · 2022 · Cancers
Digitoxin Affects Metabolism, ROS Production and Proliferation in Pancreatic Cancer Cells Differently Depending on the Cell Phenotype
Heléne Lindholm, Katarina Ejeskär, Ferenc L. M. Szekeres · 2022 · International Journal of Molecular Sciences
Azeliragon inhibits PAK1 and enhances the therapeutic efficacy of AKT inhibitors in pancreatic cancer
Weikang Kong, Lingxia Zhu, Tian Xiang Li, Jiao Chen, Bo Fan, Wenjing Ji, Chunli Zhang, Xueting Cai, Chunping Hu, Xiaoyan Sun et al. · 2023 · European Journal of Pharmacology
Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality
Timothy R. Donahue, David W. Dawson · 2016 · Trends in Endocrinology and Metabolism
The Use of Genetically Engineered Mouse Models for Studying the Function of Mutated Driver Genes in Pancreatic Cancer
Ching‐Chieh Weng, Yu‐Chun Lin, Kuang‐Hung Cheng · 2019 · Journal of Clinical Medicine
Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG)
George Zarkavelis, Vassiliki Kotoula, Georgia-Angeliki Kolliou, Kyriaki Papadopoulou, Ioannis Sotirios Tikas, Vasilios Karavasilis, Epaminontas Samantas, Christos Dervenis, Ioannis Efstratiou, Irene Nicolaou et al. · 2019 · ESMO Open
Beyond the Genomic Mutation: Rethinking the Molecular Biomarkers of K-RAS Dependency in Pancreatic Cancers
Carla Mottini, Luca Cardone · 2020 · International Journal of Molecular Sciences
Effect of Fucoxanthinol on Pancreatic Ductal Adenocarcinoma Cells from anN-Nitrosobis(2-oxopropyl)amine-initiated Syrian Golden Hamster Pancreatic Carcinogenesis Model
Masaru Terasaki, YUSAKU NISHIZAKA, Wataru Murase, Atsuhito Kubota, Hiroyuki Kojima, Mareshige Kojoma, Takuji Tanaka, H. Maeda, Kazuo Miyashita, Michihiro Mutoh et al. · 2021 · Cancer Genomics & Proteomics
Molecular and Genetic Basis of Pancreatic Carcinogenesis
Vincent Bernard, Jason B. Fleming, Anirban Maitra · 2016 · Surgical Oncology Clinics of North America
The Role of Precision Medicine in Pancreatic Cancer: Challenges for Targeted Therapy, Immune Modulating Treatment, Early Detection, and Less Invasive Operations
Yi Le, KhaledKyle Wong, Zhirong Qian · 2016 · Cancer translational medicine
Increased Risk of Second Primary Cancers Following Diagnosis of Malignant Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Population-Based Study
Xiaoyi Huang, Bingbing Zhang, Jian Zhao, Chen Sun, Kaiwen Kong, Lulu Deng, Yanfang Liu, Jianming Zheng · 2019 · Frontiers in Oncology
Epigenetic regulator ARID1A and stem cell transcription factor SOX9 in the maintenance of pancreatic ductal cell differentiation state and development of intraductal papillary mucinous neoplasia (IPMN) and pancreatic ductal adenocarcinoma (PDAC)
Naipeng Cui, Jinsong Zhang, Huatian Huang, Lingeng Lu · 2018 · Translational Cancer Research
Exome sequencing of UK birth cohorts
Mahmoud Koko, Laurie Fabian, Iaroslav Popov, Ruth Y. Eberhardt, Gennadii A. Zakharov, Qin Qin Huang, Emma E. Wade, Rafaq Azad, Petr Danecek, Karen M. Ho et al. · 2024 · Wellcome Open Research
Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications
Jörg Tost, Seçil Ak Aksoy, Daniele Campa, Chiara Corradi, Riccardo Farinella, Alejandro Ibáñez‐Costa, Juan Dubrot, Julie Earl, Emma Barreto Melian, Agapi Kataki et al. · 2025 · Seminars in Cancer Biology
Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions
Chengwei Peng, Paul E. Oberstein · 2025 · Current Treatment Options in Oncology
Overexpression of RBM10 induces osteosarcoma cell apoptosis and inhibits cell proliferation and migration
Liping Han, Cun-ping Wang, Si-lin Han · 2018 · médecine/sciences
Diagnostic value of digital droplet polymerase chain reaction and digital multiplexed detection of single-nucleotide variants in pancreatic cytology specimens collected by EUS-guided FNA
Irina Mihaela Cazacu, Alexander Semaan, Bret M. Stephens, Daniel B. Swartzlander, Paola A. Guerrero, Ben S. Singh, Cristian Virgil Lungulescu, Mihaela Dănciulescu, Irina F. Cherciu Harbiyeli, Ioana Streață et al. · 2020 · Gastrointestinal Endoscopy
Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?
Nebojša Skorupan, Shadin Ghabra, Jose Alberto Maldonado, Yang Zhang, Christine Alewine · 2023 · Journal of Cancer Metastasis and Treatment
Oncogenic signaling pathways in pancreatic ductal adenocarcinoma
Rahul Agrawal, Kedar Nath Natarajan · 2023 · Advances in cancer research
Genetic Profiling of Cancers of the Digestive System: Biological Insights and Clinical Implications
Albrecht Stenzinger, Wilko Weichert · 2017 · Pathobiology
Mechanisms of Gastrointestinal Malignancies
Bryson W. Katona, John P. Lynch · 2018 · Elsevier eBooks
Association of Pioglitazone with Increased Risk of Prostate Cancer and Pancreatic Cancer: A Functional Network Study
Weiheng Wen, Peili Wu, Jinru Gong, Min Zhao, Zhen Zhang, Rongping Chen, Hong Chen, Jia Man Sun · 2018 · Diabetes Therapy
TGF-β signaling promotes tube-structure-forming growth in pancreatic duct adenocarcinoma
Takashi Yamaguchi, Sanae Kabata Ikehara, Yoshihiro Akimoto, Hayao Nakanishi, Masahiko Kume, Kazuo Yamamoto, Osamu Ohara, Yuzuru Ikehara · 2019 · Scientific Reports
Upfront molecular profiling of pancreatic cancer patients – An idea whose time has come
Manoop S. Bhutani, Irina Mihaela Cazacu, Sinchita Roy‐Chowdhuri, Anirban Maitra, Michael Jon Pishvaian · 2020 · Pancreatology
Biointerface mediates cytoskeletal rearrangement of pancreatic cancer cell and modulates its drug sensitivity
Jing Hui Dai, Yiqun Wang, Dinghao Wu, Fengju Wan, Yi Lü, Na Kong, Xiuchun Li, Jinkang Gong, Shengjie Ling, Yuan Yao · 2020 · Colloids and Interface Science Communications
FoundationOne® CDx gene profiling in Japanese pancreatic ductal adenocarcinoma patients: a single-institution experience
Ryuichiro Kimura, Takao Ohtsuka, Makoto Kubo, Atsuko Kajihara, Atsushi Fujii, Yusuke Watanabe, Yasuhisa Mori, Naoki Ikenaga, Kohei Nakata, Koji Shindo et al. · 2020 · Surgery Today
Aberrant (pro)renin receptor expression induces genomic instability in pancreatic ductal adenocarcinoma through upregulation of SMARCA5/SNF2H
Yuki Shibayama, Kazuo Takahashi, Hisateru Yamaguchi, Jun Yasuda, Daisuke Yamazaki, Asadur Rahman, Takayuki Fujimori, Yoshihide Fujisawa, Shinji Takai, Toru Furukawa et al. · 2020 · Communications Biology
PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer
Lucia Liotta, Sebastian Lange, H. Carlo Maurer, Kenneth P. Olive, Rickmer Braren, Nicole Pfarr, Sebastian Bürger, Alexander Muckenhuber, Moritz Jesinghaus, Katja Steiger et al. · 2021 · JCI Insight
Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients
Fumiaki Watanabe, Koichi Suzuki, Sawako Tamaki, Iku Abe, Yuhei Endo, Yuji Takayama, Hideki Ishikawa, Nao Kakizawa, Masaaki Saito, Kazushige Futsuhara et al. · 2021 · Scientific Reports
Proteogenomic analysis of pancreatic cancer subtypes
Doris Kafita, Panji Nkhoma, Mildred Zulu, Musalula Sinkala · 2021 · PLoS ONE
Genetic Alterations Predict Long-Term Survival in Ductal Adenocarcinoma of the Pancreatic Head
Sami Alexander Safi, Lena Häberle, Wolfgang Goering, Verena Keitel, Georg Fluegen, Nikolas Hendrik Stoecklein, Alexander Rehders, Wolfram Trudo Knoefel, Iréne Esposito · 2022 · Cancers
Molecular Pathology of Pancreatic Cancer
Eva Karamitopoulou · 2022 · Cancers
Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9
Masato Ono, Yusuke Ono, Toru Nakamura, Takahiro Tsuchikawa, Tomotaka Kuraya, Shota Kuwabara, Yoshitsugu Nakanishi, Toshimichi Asano, Aya Matsui, Kimitaka Tanaka et al. · 2022 · Annals of Surgical Oncology
Clinical and genetic characteristics in pancreatic cancer from Chinese patients revealed by whole exome sequencing
Yonggang He, Wen Jing Huang, Yichen Tang, Yuming Li, Xuehui Peng, Jing Li, Jing Yun Wu, Nan You, Ling Li, Chuang Liu et al. · 2023 · Frontiers in Oncology
Identification of hallmarks of lung adenocarcinoma prognosis using whole genome sequencing
Li Liu, Jiao Huang, Ke Wang, Li Li, Yangkai Li, Jingsong Yuan, Sheng Wei · 2015 · Oncotarget
Safety of palliative chemotherapy in advanced pancreatic cancer
Christoph Benedikt Westphalen, Stephan Krüger, Michael Haas, Volker Heinemann, Stefan Hubert Boeck · 2016 · Expert Opinion on Drug Safety
Functional network analysis reveals potential repurposing of β-blocker atenolol for pancreatic cancer therapy
Adam Hermawan, Herwandhani Putri, Rohmad Yudi Utomo · 2020 · DARU Journal of Pharmaceutical Sciences
TLR2 and TLR9 Blockade Using Specific Intrabodies Inhibits Inflammation-Mediated Pancreatic Cancer Cell Growth
Amrendra K. Ajay, Martin Gasser, Li‐Li Hsiao, Thomas W. Böldicke, Ana Maria Waaga-Gasser · 2024 · Antibodies
GRP78 inhibitor YUM70 upregulates 4E-BP1 and suppresses c-MYC expression and viability of oncogenic c-MYC tumors
Vicky N. Yamamoto, Dat P. Ha, Ze Liu, Miller Huang, Soma Samanta, Nouri Neamati, Amy Shiu Lee · 2024 · Neoplasia
Association of epigenetic landscapes with heterogeneity and plasticity in pancreatic cancer
Paul Manoukian, Leo C Kuhnen, Hanneke W.M. van Laarhoven, Maarten F. Bijlsma · 2024 · Critical Reviews in Oncology/Hematology
Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer
Elisabetta Broseghini, Federico Venturi, Giulia Veronesi, Biagio Scotti, Marina Migliori, Desy Marini, Claudio Ricci, Riccardo Casadei, Manuela Ferracin, Emi Dika · 2024 · Pigment Cell & Melanoma Research
Fibroblast STAT3 Activation Drives Organ-Specific Premetastatic Niche Formation
Emily L. Lasse Opsahl, Carlos E. Espinoza, Alberto C. Olivei, Jude Ogechukwu Okoye, Hannah R. Watkoske, Megan T. Hoffman, Faith R. Avritt, Ahmed M. Elhossiny, Allison C. Bischoff, Katelyn L. Donahue et al. · 2025 · Cancer Research
Susceptibility loci for pancreatic cancer in the Brazilian population
Mateus Nóbrega Aoki, Angelika Stein, Jaqueline Carvalho de Oliveira, Roger J. Chammas, Miyuki Uno, Francielle Boçon de Araújo Munhoz, Anelis Maria Marin, Federico Canzian · 2021 · BMC Medical Genomics
Germline DNA damage repair gene mutations in pancreatic cancer patients with personal/family histories of pancreas/breast/ovarian/prostate cancer in a Japanese population
Tatsuo Hata, Masamichi Mizuma, Fuyuhiko Motoi, Masaharu Ishida, Hideo Ohtsuka, Kei Nakagawa, Takanori Morikawa, Toru Furukawa, Michiaki Unno · 2021 · Annals of Gastroenterological Surgery
Aberrant transcription factors in the cancers of the pancreas
Md. Hafiz Uddin, Md Najeeb Al-Hallak, Philip A. Philip, Herbert Chen, Bassel F. El‐Rayes, Asfar Sohail Azmi · 2022 · Seminars in Cancer Biology